Search
Lincomycin
go.drugbank.com/drugs/DB01627ApprovedInvestigationalVet approved[A190657, A190621] Lincomycin was approved by the FDA on December 29, 1964.[L33214] … [A190621] Clinical use of lincomycin has largely been superseded by its semisynthetic derivative [clindamycin] due to its higher efficacy and a wider range of susceptible organisms, though lincomycin remains
Categories: Heterocyclic Compounds, 1-RingProducts: LINCOCIN 2 ML 600 MG 1 AMPUL, LINKAMIN ENJEKTABL 600 MG/2 ML, 1 ADETDiphenhydramine
go.drugbank.com/drugs/DB01075ApprovedInvestigationalDiphenhydramine - perhaps known most commonly as its brand name formulation Benadryl - is a first-generation H1 receptor antihistamine that is used extensively for the treatment of seasonal allergies, insect bites and stings, and rashes ...
Mixtures: Benadryl Bug Bite Relief, Tylotus Night 325 mg+5 mg+12,5 mg/15 mL Oral ÇözeltiProducts: ALLERJIN 10 MG/4 ML 100 ML SURUP, DIFENHIDRAMINA HCL SOLUCION INYECTABLE 10 MG/ MLFlorquinitau (18F)
go.drugbank.com/drugs/DB19215Approved[L64052] Florquinitau F 18, also known as MK-6240, was approved by the FDA on August 14, 2026 for PET of the brain in adults with cognitive impairment who are being evaluated for Alzheimer's disease … Florquinitau F 18 is a radioactive diagnostic drug used as a fluorine-18–labeled positron emission tomography (PET) tracer.
Synonyms: 6-fluoro-3-(1h-pyrrolo(2,3-c)pyridin-1-yl)isoquinolin-5-amine, 5-isoquinolinamine, 6-(fluoro-18f)-3-(1h-pyrrolo(2,3-c)pyridin-1-yl)-Selumetinib
go.drugbank.com/drugs/DB11689ApprovedInvestigational[A193533] Following its initial FDA approval on April 10, 2020,[L49991] and Health Canada approval on August 23, 2022,[L49986] the regulatory landscape has evolved. … NF-1 is considered rare, with an estimated incidence of 1/3000 individuals.
Categories: Mitogen-Activated Protein Kinase Kinase 1 InhibitorsProducts: Koselugo Hard Capsules 10 mg, Koselugo Hard Capsules 25 mgDisintegrin and metalloproteinase domain-containing protein 10
go.drugbank.com/bio_entities/BE0002404TargetHumansTransmembrane metalloprotease which mediates the ectodomain shedding of a myriad of transmembrane proteins, including adhesion proteins, growth factor precursors and cytokines being essential for development and tissue homeostasis (PubMe...
Polypeptides: Disintegrin and metalloproteinase domain-containing protein 10Synonyms: ADAM 10Sialic acid-binding Ig-like lectin 10
go.drugbank.com/bio_entities/BE0018431TargetHumansPutative adhesion molecule that mediates sialic-acid dependent binding to cells. Preferentially binds to alpha-2,3- or alpha-2,6-linked sialic acid (By similarity). The sialic acid recognition site may be masked by cis interactions with ...
Polypeptides: Sialic acid-binding Ig-like lectin 10Synonyms: Siglec-10Zafirlukast
go.drugbank.com/drugs/DB00549ApprovedZafirlukast is an oral leukotriene receptor antagonist (LTRA) for the maintenance treatment of asthma, often used in conjunction with an inhaled steroid and/or long-acting bronchodilator. It is available as a tablet and is usually dosed ...
Synonyms: 4-(5-cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-o-tolylsulfonylbenzamide, cyclopentyl 3-(2-methoxy-4-((o-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamateProducts: CARROX 10 MG FILM TABLET, 28 TABLET, CARROX 10 MG FILM TABLET, 56 TABLETUstekinumab
go.drugbank.com/drugs/DB05679ApprovedInvestigational[A187349] It was generated via recombinant human IL-12 immunization of human Ig (hu-Ig) transgenic mice. … In October 2019, it was also approved by the FDA for use to manage moderately to severely active ulcerative colitis in adults.
Categories: Interleukin-12 AntagonistProducts: STELARA 130 MG, STELARA® 90 MG/MLManganese gluconate
go.drugbank.com/drugs/DB11141ApprovedIt is typically obtained by reacting manganese carbonate with gluconic acid in aqueous medium and then crystallizing the product to form a slightly pink powder.
Mixtures: Vital Be-100, Cal-mag Plus K, Mn and Zn CapletsProducts: Manganese (gluconate) 10 Mg TabletsClopidogrel
go.drugbank.com/drugs/DB00758ApprovedInvestigational[A180547] Clopidogrel was granted FDA approval on 17 November 1997.[L7213] … L7213] Clopidogrel is indicated to reduce the risk of myocardial infarction for patients with non-ST elevated acute coronary syndrome (ACS), patients with ST-elevated myocardial infarction, and in recent MI
Mixtures: CoPlavix Film-Coated Tablet 75 mg/100 mg, KLOGEL-A 75/100 MG KAPSUL, 30 ADETCategories: Heterocyclic Compounds, 1-Ring